RVL Pharmaceuticals plc Accounts Receivable, Credit Loss Expense (Reversal)
RVL Pharmaceuticals plc reported Accounts Receivable, Credit Loss Expense (Reversal) of $5.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2022-05-12
- RVL Pharmaceuticals plc accounts receivable, credit loss expense (reversal) for the quarter ending 2021-03-31 was $5.00K, a 82.76% decline year-over-year.
- RVL Pharmaceuticals plc accounts receivable, credit loss expense (reversal) for the quarter ending 2020-12-31 was $0.00.
- RVL Pharmaceuticals plc accounts receivable, credit loss expense (reversal) for the quarter ending 2020-09-30 was -$4.00K.
- RVL Pharmaceuticals plc accounts receivable, credit loss expense (reversal) for the quarter ending 2020-06-30 was -$19.00K.
- RVL Pharmaceuticals plc accounts receivable, credit loss expense (reversal) for fiscal 2020 was $6.00K.
- RVL Pharmaceuticals plc accounts receivable, credit loss expense (reversal) for fiscal 2018 was -$1.77M.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 3 month as first filed | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month as first filed | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month as first filed | Accounts Receivable, Credit Loss Expense (Reversal) 12 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | $5.00K 10-Q · filed 2022-05-12 | $5.00K derived: sum of 2 quarters · filed 2022-05-12 | $1.00K derived: sum of 3 quarters · filed 2022-05-12 | -$18.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$4.00K derived: sum of 2 quarters · filed 2022-03-30 | -$23.00K derived: sum of 3 quarters · filed 2022-03-30 | $6.00K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$23.00K derived: sum of 2 quarters · filed 2021-11-15 | $6.00K 10-Q · filed 2021-11-15 | $2.00K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $10.00K 10-Q · filed 2020-08-11 | $6.00K derived: sum of 3 quarters · filed 2021-09-08 | $3.00K derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2020-03-31 | $29.00K 10-Q · filed 2021-05-13 | $25.00K derived: sum of 2 quarters · filed 2021-09-08 | $22.00K derived: sum of 3 quarters · filed 2021-09-08 | -$51.00K derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2019-12-31 | -$4.00K derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | -$7.00K derived: sum of 2 quarters · filed 2021-09-08 | -$80.00K derived: sum of 3 quarters · filed 2021-09-08 | -$164.00K 8-K · filed 2021-09-08 | ||||
| 2019-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$76.00K derived: sum of 2 quarters · filed 2020-11-10 | -$160.00K 10-Q · filed 2020-11-10 | -$160.18K 10-Q · filed 2019-11-14 | -$638.00K derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | -$73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$157.00K 10-Q · filed 2020-08-11 | -$157.18K 10-Q · filed 2019-08-08 | -$635.00K derived: sum of 3 quarters · filed 2020-08-11 | -$1.69M derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | -$84.00K 10-Q · filed 2020-05-12 | -$84.30K 10-Q · filed 2019-05-09 | -$562.00K derived: sum of 2 quarters · filed 2020-05-12 | -$1.62M derived: sum of 3 quarters · filed 2020-05-12 | -$1.76M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | -$478.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | -$1.53M derived: sum of 2 quarters · filed 2020-03-19 | -$1.67M derived: sum of 3 quarters · filed 2020-03-19 | -$1.77M 10-K · filed 2020-03-19 | -$1.77M 10-K · filed 2019-03-28 | |||
| 2018-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$1.19M derived: sum of 2 quarters · filed 2019-11-14 | -$1.29M 10-Q · filed 2019-11-14 | $591.75K derived: sum of 4 quarters · filed 2019-12-20 | ||||
| 2018-06-30 | -$139.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$239.60K 10-Q · filed 2019-08-08 | $1.65M derived: sum of 3 quarters · filed 2019-12-20 | |||||
| 2018-03-31 | -$99.80K 10-Q · filed 2019-05-09 | $1.78M derived: sum of 2 quarters · filed 2019-12-20 | ||||||
| 2017-12-31 | $1.88M derived: 8-K 12 month − 10-Q 9 month · filed 2019-12-20 | $832.39K 8-K · filed 2019-12-20 | ||||||
| 2017-09-30 | -$1.05M 10-Q · filed 2018-11-08 |